Corporate Profile

Advanced Neuromodulation Systems^® (ANS^®) is a compelling force within the dynamic and fast-growing neuromodulation market. The company is headquartered in Plano, Texas. All business activities are driven by ANS’ mission to develop, manufacture, and market proprietary neuromodulation devices that improve the quality of life for millions of people suffering from chronic pain or nervous system disorders, while at the same time building a world-class company with significant value for its shareholders.

ANS is committed to the advancement of cutting-edge solutions for pain management through ongoing research and development. The company is an innovative technological leader in the spinal cord stimulation (SCS) segment of the neuromodulation market, providing pain management solutions for people suffering from chronic pain.

ANS’ breakthrough SCS systems – or pacemakers for pain – are Eon^®, a rechargeable implantable pulse generator system, Genesis^®, a conventional implantable pulse generator system, and Renew^®, a radio-frequency system.

ANS has built a strong intellectual property and patent portfolio in support of its electrical stimulation and drug pump platforms, which can be adapted to address many current and evolving indications. For ANS, this means expanding the size of its targeted market from $300 million in 2001 to over $1 billion by 2005.

In accordance with the company’s aggressive growth initiatives, ANS acquired Hi-tronics Design, Inc., to develop and manufacture sophisticated implantable devices for ANS and other companies. Hi-tronics Designs boasts a proprietary technical design portfolio and a state-of-the-art production facility, further strengthening ANS’ position in the marketplace. The company is dedicated to the advancement of its current technology platforms through self-funded R&D, technology acquisitions, partnerships, and marketing alliances. ANS has built a highly leverageable infrastructure and is poised to begin taking advantage of its new market opportunities. The company is profitable, growing, and debt-free.

Advanced Neuromodulation Systems (ANS) became a division of St. Jude Medical (www.sjm.com) in a merger that was completed in the fourth quarter of 2005. St. Jude Medical’s acquisition of ANS taps the enormous potential of the rapidly growing, billion dollar neuromodulation market and expands St. Jude’s implantable microelectronics technology program.

St. Jude Medical is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The company has five major focus areas that include: neuromodulation, cardiac rhythm management, atrial fibrillation, cardiac surgery, and cardiology. Headquartered in St. Paul, Minnesota, the company employs approximately 10,000 people worldwide.

For St. Jude Medical investor information, please click here. For more information about ANS, visit About ANS or News Room sections of this site.